Immuneering Corporation (IMRX)
NASDAQ·Healthcare·Biotechnology
$4.07
+6.27%
Mkt Cap $241.97M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
Implied Upside
+252.5%
Consensus $14.33 vs current $4.07
NASDAQ·Healthcare·Biotechnology
$4.07
+6.27%
Mkt Cap $241.97M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$14.33
Range $12.00 – $17.00
+252.5%
Consensus $14.33 vs current $4.07